IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuettauf, F.
Right arrow Articles by Dreyer, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuettauf, F.
Right arrow Articles by Dreyer, E. B.
(Investigative Ophthalmology and Visual Science. 2000;41:4313-4316.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Ganglion Cell Loss after Optic Nerve Crush Mediated through AMPA-Kainate and NMDA Receptors

Frank Schuettauf1, Rita Naskar1, Christian K. Vorwerk1, David Zurakowski2 and Evan B. Dreyer1

1 From the Department of Ophthalmology, Veterans Administration and the University of Pennsylvania, Philadelphia; and the 2 Department of Biostatistics, Children’s Hospital, Boston, Massachusetts.

PURPOSE. Glutamate antagonists can block ganglion cell death due to optic nerve crush. Although most investigators have focused on blockade of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor, we have chosen to evaluate the efficacy of blockade of the AMPA-kainate (KA) receptor in this experimental paradigm.

METHODS. The optic nerves of rats were crushed, and ganglion cell survival was assessed. Groups of animals were treated with an NMDA antagonist, an AMPA-KA antagonist, or both.

RESULTS. The AMPA-KA antagonist DNQX was more effective, although not additive in preserving retinal ganglion cells after optic nerve crush than the NMDA antagonist MK801.

CONCLUSIONS. Activation of the AMPA-KA subtype of glutamate receptor may play a role in glutamate-mediated cell death after optic nerve crush.




This article has been cited by other articles:


Home page
 IOVSHome page
S. Thaler, C. Haritoglou, T. J. Choragiewicz, A. Messias, A. Baryluk, C. A. May, R. Rejdak, M. Fiedorowicz, E. Zrenner, and F. Schuettauf
In Vivo Toxicity Study of Rhodamine 6G in the Rat Retina
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 2120 - 2126.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
F. Schuettauf, C. Haritoglou, C. A. May, R. Rejdak, A. Mankowska, W. Freyer, K. Eibl, E. Zrenner, A. Kampik, and S. Thaler
Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3573 - 3578.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
Y. Gotoh, S. Machida, and Y. Tazawa
Selective Loss of the Photopic Negative Response in Patients With Optic Nerve Atrophy
Arch Ophthalmol, March 1, 2004; 122(3): 341 - 346.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Nakazawa, M. Tamai, and N. Mori
Brain-Derived Neurotrophic Factor Prevents Axotomized Retinal Ganglion Cell Death through MAPK and PI3K Signaling Pathways
Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3319 - 3326.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology